InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: DewDiligence post# 646

Saturday, 09/23/2017 10:07:32 AM

Saturday, September 23, 2017 10:07:32 AM

Post# of 1162
Ok. Looks like I was wrong about timing of pfe buying bmy if the rumors are right.

But did you read PFE CFO comments at MS. Looks like they can buy anyone with or without tax reform. But with tax holiday they could create up to 180 bil in buying power.

I bet on BMY after watching options skyrocket in Febuary but the CEO stated they had targets picked out. I completely dismissed AGN as it was thought an inversion play. Analyst just stated it is worth minimum of 300 and that would be without synergies. They have a good relationship and AGN would not benefit at all from tax reform. They are having the opioid issue right now.

September BMY options did skyrocket for me, but with the stock 11 bucks higher some of the premium seems built in. Some people call for 80 to 100 per share but that seems optimistic. Gonna try to November now because after that there will likely be no tax reform in December.

Bmy certainly makes sense, with eliquis and top oncology drug but there are many targets. Like CFO stated they have recently done 40 bil in deals without tax reform and that stock has rallied. It is one of our biggest holdings. BMY rumors could be head fake.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News